Pulmonary toxicity of drugs and thoracic irradiation in children;Toxicite pulmonaire des medicaments et de l'irradiation thoracique chez l'enfant

Revue des Maladies Respiratoires

Volumn 13, Issue 3, 1996, Pages 235-242

  Fauroux, B ^a   Clement A ^a   Tournier, G ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

chemotherapy; children; thoracic irradiation; toxic lung disease

Indexed keywords

BETA LACTAM ANTIBIOTIC; BLEOMYCIN; BUSULFAN; CARBAMAZEPINE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; METHOTREXATE; NITROFURANTOIN; PENICILLAMINE; PHENYTOIN; SALAZOSULFAPYRIDINE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT;

FUNCTIONAL ASSESSMENT; HUMAN; LUNG FUNCTION; LUNG TOXICITY; RADIATION EXPOSURE; RADIATION HAZARD; REVIEW; CHEMICALLY INDUCED DISORDER; CHILD; DRUG HYPERSENSITIVITY; DRUG THERAPY; HYPERSENSITIVITY; IATROGENIC DISEASE; INTERSTITIAL LUNG DISEASE; LUNG DISEASE; LUNG EDEMA; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG LAVAGE; RADIATION INJURY; RADIOTHERAPY; THORAX;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; DRUG HYPERSENSITIVITY; DRUG THERAPY; HUMANS; HYPERSENSITIVITY; IATROGENIC DISEASE; LUNG DISEASES; LUNG DISEASES, INTERSTITIAL; PULMONARY EDEMA; PULMONARY FIBROSIS; RADIATION INJURIES; RADIOTHERAPY; RESPIRATORY FUNCTION TESTS; THORAX;

EID: 0030194777     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. BLAISS MS: Drug-induced pulmonary reactions in children, a review. Southern Med J 1990;84:345-8.
2. FAUROUX B, TOURNIER G: Toxicité pulmonaire des drogues chez l'enfant. Med Infantile 1990;4:289-97.
3. FAUROUX B, MILSTZAIN A, BOCCON-GIBBOD L et al.: Cytotoxic drug-induced pulmonary disease in infants and children. Ped Pulmonol 1994;18:347-55.
4. BEGAUD B, EVREUX JC, JOUGLARD J, LAGIER G: Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Thérapie 1985;40:111-8.
5. FOURNIER M, CAMUS P, BENICHOU C et al.: Pneumopathies interstitielles: critères d'imputation à un médicament. Résultats de réunions de consensus. Presse Med 1989;18:1333-6.
6. KRAMER MS, LEVENTHAL JM, HUTCHINSON TA, FEINSTEIN AR: An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. JAMA 1979;242:623-32.
7. MA LD, TAYLOR GA, WHARAM MD, WILEY JM: «Recall» pneumonitis: adriamycin potentiation of radiation pneumonitis in two children. Radiology 1993;187:465-7.
8. O'DRISCOLL BR, HASLETON PS, TAYLOR PM, POULTER LW, GATTAMENI HR, WOODCOCK AA: Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in chilhood. N Engl J Med 1990;323:378-82.
9. ARONIN PA, MAHALEY MS, RUDNICK SA: Prediction of BCNU pulmonary toxicity in patients with malignant gliomas. An assessment of risk factors. N Engl J Med 1980;303:183-8.
10. SHAW PJ, HUGH-JONES K, HOBBS JR, DOWNIE CJC, BARNES R: Busulfan and cyclophosphamide cause little early toxicity during displacement bone marrow transplantation in fifty children. Bone Marrow Transplantation 1986;1:193-200.
11. 2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation? Blood 1992;79:2475-9.
12. GAULTIER C, GIRARD F: Croissance pulmonaire normale et pathologie. Relation structure-fonction. Bull Eur Physiopathol Respir 1980;16:791-842.
13. ALVARADO CS, BOATT F, NEWMAN AJ: Late onset pulmonary fibrosis and chest deformity in two children treated with cyclophosphamide. J Pediatr 1978;92:443-6.
14. GALVAN L, HUANG CH, PRESTAYKO AW, STOUT JT, EVANS JE, CROOKE ST: Inhibition of bleomycin-induced DNA by superoxide dismutase. Cancer Res 1981;44:5103-6.
15. ARRICK BA, NATHAN CF: Glutathione metabolism as a determinant of therapeutic efficacity: a review. Cancer Res 1984;44:4224-32.
16. TEAGUE WG, SUTPHEN JL, FECHNER RE: Desquamative interstitial pneumonitis complicating inflammatory bowel disease in children. J Pediatr Gastroenterol Nutr 1985;4: 663-6.
17. MUNCK A, MURCIANO D, PARIENTE R, CEZARD JP, NAVARRO J: Latent pulmonary function abnormalities in children with Crohn's disease. Eur Respir J 1995;8:377-80.
18. HEFFNER JE, SAHN SA: Salicylate-induced pulmonary edema, clinical features and prognosis. Ann Intern Med 1981;95:405-9.
19. ELLIS M, HAYDIK I, GILLMAN S: Immediate adverse reactions to acetaminophene. J Allergy Clin Immunol 1988;81: 180.
20. DE SWERT LF, CEUPPENS JL, TEUWEN D: Acute interstitial pneumonitis and carbamazepine therapy. Acta Pediatr Scand 1984;73:285-7.
21. O'CALLAGHAN C, MILNER AD, SWARBRICK A: Paradoxal determination in lung function after nebulized salbutamol in wheezy infants. Lancet 1986;II:8521-2;1424-5.
22. CHIN TW, NUSSBAUM E: Detrimental effect of hypotonic cromolyn sodium. J Pediatr 1992;120:641-3.
23. MENON MPS, DAS AK: Asthma and urticaria during disodium cromoglycate treatment: a case report. Scand J Resp Dis 1977;58:145-50.
24. JONES SE, MOORE M, BLANK M, CASTELLINO RA: Hypersensitivity to procarbazine (matulane) manifested by fever and pleuropulmonary reaction. Cancer 1972;29: 498-500.
25. HAILEY FJ, GLASCOCK HW, HEWITT WF: Pleuropneumonic reactions to nitrofurantoin. N Engl J Med 1969;281:1087-90.
26. WRIGHT DG, ROBICHAUD KJ, PIZZOP A: Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med 1981;304: 1185-9.
27. DUTCHER JP, KENDALL J, NORRIS D, SCHIFFER C, AISNER J, WIERWICK PH: Granulocyte transfusion therapy and amphothericin B: adverse reactions? Am J Hematol 1989;31: 102-8.
28. STERNLIEB I, BENNET B, SCHEINBERG IH: D penicillamine-induced Goodpasture's syndrome in Wilson's disease. Ann Intern Med 1975;82:673-6.
29. CAMUS P: Manifestations respiratoires associées aux traitements par la D-pénicillamine. Rev Fr Mal Respir 1982;10: 7-20.
30. GELLER M, KRIZ RJ, ZIMMERMAN SW: Penicillin-associated pulmonary hypersensitivity reaction and interstitial nephritis. Ann Allergy 1976;37:183.
31. POE RH, CONDEMI JJ, WEINSTEIN SS, SCHUSS RJ: Adult respiratory distress syndrome related to ampicillin sensitivity. Chest 1980;77:449-51.
32. DREIS DF, WINTERBAUER RH, VAN NORMAN GA: Cephalosporin-induced interstitial pneumonitis. Chest 1984; 86:138-40.
33. NELSON S, SUMMER WR, TERRY PB: Erythromycin-induced suppression of pulmonary antibacterial defenses. Am Rev Respir Dis 1987;136:1207-12.
34. BUCCA C, ROLLA G, PINNA G, OLIVA A, BUGIANI M: Hyperresponsiveness of the extrathoracic airway in patients with captopril-induced cough. Chest 1990;98:1133-7.
35. MELLONI B, VERGENEGRE A, BONNAUD F et al.: Pneumopathie induite par le pirindopril. Rev Mal Respir 1994;11:308-11.
36. BROQUESTAS J, ARAN X, SOLER J: Oxprenolol-induced life threatening bronchospasm (letter). Chest 1985;87:555.
37. LOMBARD JN, BONNOTTE B, MAYNADIÉ M et al.: Celiprolol pneumonitis. Eur Respir J 1993;6:558-91.
38. GAUTHIER-RAHMAN S, MORLAT JL, LECA G, BOUIN M: A rapid photoelectric method for reading cell migration from agarose microdroplets. J Immunol Methods 1982;53:77-89.
39. LEVACHER M, ROUVEIX B, BADENOCH-JONES P: Diagnosis of penicillin allergy. An evaluation of the leucocyte aggregation test in man. Clin Allergy 1983;13:21-9.
40. ROUVEIX B: Le test d'agrégation leucocytaire dans l'évaluation de l'immunité à médiation cellulaire. Adaptation à l'allergie médicamenteuse. Nouv Presse Méd 1982;11:843-6.
41. PERRY DJ, WEISS RB, TAYLOR HG: Enhanced bleomycin toxicity during acute renal failure. Cancer Treat Rep 1982;66:592-3.
42. MAHLER J, DALY PA: Severe bleomycin lung toxicity: reversal with high dose corticosteroids. Thorax 1993;48:92-4.
43. GROSS NJ: Pulmonary effects of radiation therapy. Annales Intern Med 1977;86:81-92.
44. PHILLIPS TL, WYATT JR: Radiation fibrosis. In: Fishman AP, ed, Pulmonary diseases and disorders. Vol I. NewYork: MacGraw-Hill 1980;658-75.
45. COGGLE JE, LAMBERT BE, MOORES SR: Radiation effects in the lung. Environ Health Perspectives 1986;70:261-91.
46. GROSS NJ: Experimental radiation pneumonitis IV. Leakage of circulatory proteins on to the alveolar surface. J Lab Clin Med 1980;95:19-31.
47. GROSS NJ: Early physiologic and biochemical effects of thoracic X-irradiation on the pulmonary surfactant system. J Lab Clin Med 1978;91:537-44.
48. PARRIS TM, KNIGHT JG, HESS CE, CONSTABLE WC: Severe radiation pneumonitis precipitated by withdrawal of corticosteroids: a diagnosis and therapeutic dilemma. Am J Roentgenol 1979;132:284-6.
49. GROSS NJ: Radiation pneumonitis in mice. Some effects of corticosteroids on mortality and pulmonary physiology. J Clin Invest 1980;66:504-10.
50. MOSS WT, HADDY FJ, SWEANY SK: Some factors altering the severity of acute radiation pneumonitis: variation with cortisone, heparin and antibiotics. Radiology 1960;75:50-4.
51. WOHL ME, THORN GRISCOM N, TRAGGIS DG JAFFE N: Effects of therapeutic irradiation delivered in early chilhood upon subsequent lung function. Pediatrics 1975;55:507-16.
52. BENOIST MR, LEMERLE J, JEAN R, RUFIN P, SCHEINMANN P, PAUPE J: Effects on pulmonary function of whole lung irradiation for Wilms' tumour in children. Thorax 1982;37: 175-80.
53. MILLER RW, FUSNER JE, FINK RJ et al.: Pulmonary function abnormalities in long term survivors of chilhood cancer. Med Pediatr Oncol 1986;14:202-7.
54. THOMAS PRM, TEFFT M, D'ANGIO GJ, NORKOOL P: Acute toxicities associated with radiotherapy in the Second National Wilms' Tumour Study. J Clin Oncol 1988;6: 1694-8.
55. LITTMAN P, MEADOW AT, POLGAR G, BORNS PF, RUBIN E: Pulmonary function in survivors of Wilms' tumour. Patterns of impairment. Cancer 1976;37:2773-6.
56. BOULE M, ZUCKER JM, GAULTIER C et al.: Lung function of children treated for malignant extrapulmonary tumours. Bull Eur Physiopathol Respir 1984;20:121-6.
57. SHAW NJ, EDEN OB, JENNY MEM et al.: Pulmonary function in survivors of Wilms' tumour. Pediatr Hematol Oncol 1991;8:131-7.
58. ATTARD-MONTALTO SP, KINGSTON JE, EDEN OB, PLOWMAN PN: Late follow-up of lung function after whole lung irradiation for Wilms' tumour. British J Radiol 1992;66:1114-8.